Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. Being a pharmaceutical company, it provides medicinal products including fertility-regulating drugs, Uygur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
1993
3.7K+
LTM Revenue n/a
LTM EBITDA n/a
$5.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Humanwell Healthcare has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Humanwell Healthcare achieved revenue of $3.4B and an EBITDA of $627M.
Humanwell Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Humanwell Healthcare valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $3.4B | n/a | XXX | XXX | XXX |
Gross Profit | $1.2B | $1.3B | XXX | XXX | XXX |
Gross Margin | 36% | NaN% | XXX | XXX | XXX |
EBITDA | $627M | n/a | XXX | XXX | XXX |
EBITDA Margin | 19% | NaN% | XXX | XXX | XXX |
Net Profit | $181M | $342M | XXX | XXX | XXX |
Net Margin | 5% | NaN% | XXX | XXX | XXX |
Net Debt | $690M | $450M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Humanwell Healthcare's stock price is CNY 21 (or $3).
Humanwell Healthcare has current market cap of CNY 33.7B (or $4.6B), and EV of CNY 38.4B (or $5.3B).
See Humanwell Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$5.3B | $4.6B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Humanwell Healthcare has market cap of $4.6B and EV of $5.3B.
Humanwell Healthcare's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Humanwell Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Humanwell Healthcare and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $5.3B | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHumanwell Healthcare's NTM/LTM revenue growth is n/a
Humanwell Healthcare's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Humanwell Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Humanwell Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Humanwell Healthcare and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.9M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 14% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
Opex to Revenue | 31% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Humanwell Healthcare acquired XXX companies to date.
Last acquisition by Humanwell Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Humanwell Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Humanwell Healthcare founded? | Humanwell Healthcare was founded in 1993. |
Where is Humanwell Healthcare headquartered? | Humanwell Healthcare is headquartered in China. |
How many employees does Humanwell Healthcare have? | As of today, Humanwell Healthcare has 3.7K+ employees. |
Is Humanwell Healthcare publicy listed? | Yes, Humanwell Healthcare is a public company listed on SHG. |
What is the stock symbol of Humanwell Healthcare? | Humanwell Healthcare trades under 600079 ticker. |
When did Humanwell Healthcare go public? | Humanwell Healthcare went public in 1997. |
Who are competitors of Humanwell Healthcare? | Similar companies to Humanwell Healthcare include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Humanwell Healthcare? | Humanwell Healthcare's current market cap is $4.6B |
Is Humanwell Healthcare profitable? | Yes, Humanwell Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.